Borderline personality disorder and prior suicide attempts define a severity gradient among hospitalized adolescent suicide attempters.


Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
04 11 2020
Historique:
received: 26 04 2020
accepted: 23 10 2020
entrez: 5 11 2020
pubmed: 6 11 2020
medline: 11 2 2021
Statut: epublish

Résumé

Borderline personality disorder (BPD) and history of prior suicide attempt (SA) have been shown to be high predictors for subsequent suicide. However, no previous study has examined how both factors interact to modify clinical and suicide severity among adolescents. This study presents a comprehensive assessment of 302 adolescents (265 girls, mean age = 14.7 years) hospitalized after a SA. To test clinical interactions between BPD and history of prior SA, the sample was divided into single attempters without BPD (non-BPD-SA, N = 80), single attempters with BPD (BPD-SA, N = 127) and multiple attempters with BPD (BPD-MA, N = 95). Univariate analyses revealed a severity gradient among the 3 groups with an additive effect of BPD on the clinical and suicide severity already conferred by a history of SA. This gradient encompassed categorical (anxiety and conduct disorders and non-suicidal-self-injury [NSSI]) and dimensional comorbidities (substance use and depression severity) and suicide characteristics (age at first SA). According to regression analyses, the BPD-MA group that was associated with the most severe clinical presentation also showed specific features: the first SA at a younger age and a higher prevalence of non-suicidal self-injury (NSSI) and anxiety disorders. The BPD-MA group was not associated with higher impulsivity or frequency of negative life events. Based on these findings and to improve youth suicide prevention, future studies should systematically consider BPD and the efficacy of reinforcing early interventions for anxiety disorders and NSSI.

Sections du résumé

BACKGROUND
Borderline personality disorder (BPD) and history of prior suicide attempt (SA) have been shown to be high predictors for subsequent suicide. However, no previous study has examined how both factors interact to modify clinical and suicide severity among adolescents.
METHODS
This study presents a comprehensive assessment of 302 adolescents (265 girls, mean age = 14.7 years) hospitalized after a SA. To test clinical interactions between BPD and history of prior SA, the sample was divided into single attempters without BPD (non-BPD-SA, N = 80), single attempters with BPD (BPD-SA, N = 127) and multiple attempters with BPD (BPD-MA, N = 95).
RESULTS
Univariate analyses revealed a severity gradient among the 3 groups with an additive effect of BPD on the clinical and suicide severity already conferred by a history of SA. This gradient encompassed categorical (anxiety and conduct disorders and non-suicidal-self-injury [NSSI]) and dimensional comorbidities (substance use and depression severity) and suicide characteristics (age at first SA). According to regression analyses, the BPD-MA group that was associated with the most severe clinical presentation also showed specific features: the first SA at a younger age and a higher prevalence of non-suicidal self-injury (NSSI) and anxiety disorders. The BPD-MA group was not associated with higher impulsivity or frequency of negative life events.
CONCLUSIONS
Based on these findings and to improve youth suicide prevention, future studies should systematically consider BPD and the efficacy of reinforcing early interventions for anxiety disorders and NSSI.

Identifiants

pubmed: 33148207
doi: 10.1186/s12888-020-02930-4
pii: 10.1186/s12888-020-02930-4
pmc: PMC7643473
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

525

Références

J Can Acad Child Adolesc Psychiatry. 2018 Aug;27(3):155-156
pubmed: 30038651
J Pers Disord. 2012 Dec;26(6):927-38
pubmed: 23281677
Lancet. 2016 Mar 19;387(10024):1227-39
pubmed: 26385066
PLoS One. 2013;8(3):e59955
pubmed: 23544113
Hosp Community Psychiatry. 1987 Apr;38(4):390-3
pubmed: 3570186
J Abnorm Child Psychol. 2012 Jan;40(1):35-44
pubmed: 21853377
Clin Psychol Rev. 2008 Jul;28(6):969-81
pubmed: 18358579
Psychiatry Res. 2013 Aug 15;208(3):252-6
pubmed: 23747235
J Consult Clin Psychol. 2020 Jun;88(6):570-581
pubmed: 32162931
Suicide Life Threat Behav. 2003 Winter;33(4):389-99
pubmed: 14695054
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
Am J Psychiatry. 2004 Mar;161(3):437-43
pubmed: 14992968
J Pers Disord. 2011 Oct;25(5):607-19
pubmed: 22023298
BMC Psychiatry. 2011 Sep 30;11:158
pubmed: 21961882
Am J Psychiatry. 1994 Jul;151(7):1043-7
pubmed: 8010362
Am J Psychiatry. 2011 Dec;168(12):1266-77
pubmed: 22193671
Front Psychol. 2018 Oct 16;9:1962
pubmed: 30459673
Psychiatry Res. 2014 Jun 30;222(3):131-9
pubmed: 24656768
Psychiatry Res. 2018 Jun;264:46-53
pubmed: 29626831
World Psychiatry. 2014 Jun;13(2):153-60
pubmed: 24890068
Psychiatry Res. 2017 Mar;249:321-326
pubmed: 28152466
Am J Psychiatry. 2009 Apr;166(4):418-26
pubmed: 19223438
J Am Acad Child Adolesc Psychiatry. 2008 Jan;47(1):32-40
pubmed: 18174823
Psychiatry Res. 2013 Dec 30;210(3):957-61
pubmed: 24207008
BMC Psychiatry. 2008 Mar 06;8:15
pubmed: 18325111
Adolesc Health Med Ther. 2018 Nov 23;9:199-210
pubmed: 30538595
Personal Disord. 2018 Sep;9(5):429-436
pubmed: 28857585
Can J Psychiatry. 2015 Feb;60(2 Suppl 1):S27-36
pubmed: 25886668
Eur Child Adolesc Psychiatry. 2009 Sep;18(9):575-81
pubmed: 19390770
Lancet. 2012 Jun 23;379(9834):2373-82
pubmed: 22726518
Am J Psychiatry. 2001 Mar;158(3):427-32
pubmed: 11229984
J Abnorm Psychol. 2003 Aug;112(3):375-81
pubmed: 12943016
Pediatrics. 2007 Sep;120(3):669-76
pubmed: 17766542
Psychiatr Clin North Am. 2018 Dec;41(4):583-593
pubmed: 30447726
Child Psychiatry Hum Dev. 2016 Apr;47(2):202-14
pubmed: 26003420
Am J Psychiatry. 1994 Sep;151(9):1316-23
pubmed: 8067487
Front Psychol. 2017 Nov 30;8:2054
pubmed: 29250007
J Am Acad Child Adolesc Psychiatry. 2002 Jun;41(6):723-30
pubmed: 12049447
Eur Child Adolesc Psychiatry. 2015 Apr;24(4):397-406
pubmed: 25084977
Can J Psychiatry. 2015 Feb;60(2 Suppl 1):S46-54
pubmed: 25886671
Mol Psychiatry. 2014 Aug;19(8):902-9
pubmed: 24126928
JAMA Psychiatry. 2015 May;72(5):475-82
pubmed: 25806661
J Pers Disord. 2012 Jun;26(3):468-80
pubmed: 22686233
Suicide Life Threat Behav. 2004 Summer;34(2):113-25
pubmed: 15191268
J Child Psychol Psychiatry. 2015 Dec;56(12):1266-88
pubmed: 26251037
J Affect Disord. 2008 Apr;107(1-3):107-16
pubmed: 17804082
Can J Psychiatry. 2015 Feb;60(2 Suppl 1):S37-45
pubmed: 25886670
Personal Ment Health. 2013 May;7(2):89-101
pubmed: 24343935
Am J Psychiatry. 1990 Feb;147(2):161-7
pubmed: 2301653
Am J Psychiatry. 2007 Jul;164(7):1035-43
pubmed: 17606655
Am J Psychiatry. 2005 Feb;162(2):297-303
pubmed: 15677594
J Am Acad Child Adolesc Psychiatry. 1998 May;37(5):488-94
pubmed: 9585650
Eur Child Adolesc Psychiatry. 2011 Feb;20(2):103-8
pubmed: 21222215
Gen Hosp Psychiatry. 2019 Jan - Feb;56:54-55
pubmed: 30503219
Annu Rev Clin Psychol. 2014;10:1-24
pubmed: 24387236
Lancet. 2012 Jan 21;379(9812):236-43
pubmed: 22100201
J Clin Epidemiol. 2001 Apr;54(4):343-9
pubmed: 11297884
Curr Opin Psychiatry. 2018 Jan;31(1):57-62
pubmed: 29049100
Psychiatry Res. 2016 Dec 30;246:261-266
pubmed: 27728869
J Affect Disord. 2017 Jun;215:37-48
pubmed: 28315579
Clin Psychol Rev. 2010 Aug;30(6):768-78
pubmed: 20619943
J Affect Disord. 2010 Jul;124(1-2):202-6
pubmed: 20004477
Arch Gen Psychiatry. 2011 Aug;68(8):827-37
pubmed: 21464343
J Am Acad Child Adolesc Psychiatry. 1993 May;32(3):521-9
pubmed: 8496115
J Abnorm Psychol. 2005 Nov;114(4):551-6
pubmed: 16351377
J Abnorm Psychol. 2013 Feb;122(1):231-237
pubmed: 23067259
ScientificWorldJournal. 2012;2012:825189
pubmed: 22654633
Behav Sci Law. 2008;26(6):779-97
pubmed: 19039790
J Child Psychol Psychiatry. 2019 Jan;60(1):91-99
pubmed: 29492978
J Clin Psychiatry. 2014 May;75(5):e457-64
pubmed: 24922498
Can Child Adolesc Psychiatr Rev. 2004 Aug;13(3):51-2
pubmed: 19030499

Auteurs

Aveline Aouidad (A)

Hopital Universitaire Pitie Salpetriere, Paris, France. aveline.aouidad@aphp.fr.

David Cohen (D)

Institut des Systemes Intelligents et de Robotique, Paris, France.

Bojan Mirkovic (B)

Hopital Charles Nicolle, Rouen, France.

Hugues Pellerin (H)

Hopital Universitaire Pitie Salpetriere, Paris, France.

Sébastien Garny de La Rivière (S)

Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France.

Angèle Consoli (A)

Hopital Universitaire Pitie Salpetriere, Paris, France.

Priscille Gérardin (P)

Hopital Charles Nicolle, Rouen, France.

Jean-Marc Guilé (JM)

Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH